In this study, patients were randomized in a 1:1:1:1 ratio to a daily morning dose of VYVANSE (30 mg/day, 50 mg/day or 70 mg/day) or placebo for a total of four weeks of treatment
This is part of your bodys natural fight or flight response
The Role of GLP-1 The GLP-1 component is largely responsible for the feeling of fullness. It targets receptors in the brain that tell you when you have had enough to eat
During this visit, we will discuss your medical history, current health status, and treatment goals
In addition to helping control diabetes and stimulate weight loss, GLP-1 receptor agonists are believed to have anti-inflammatory properties
Although international regulatory frameworks differ, universal compliance is essential, mandating that manufacturers satisfy specific safety and efficacy standards established by health authorities for products classified as foods or dietary supplements (563)